Bnp Paribas Asset Management Holding S.A. Theravance Biopharma, Inc. Transaction History

Bnp Paribas Asset Management Holding S.A.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 13, 2018	SELL	$22.83 - $32.67 $5.43 Million - $7.78 Million	-238,015 Closed	0 $0
Q2 2018 Aug 01, 2018	BUY	$22.06 - $25.52 $331,605 - $383,616	15,032 Added 6.74%	238,015 $5.4 Million
Q1 2018 May 07, 2018	BUY	$23.37 - $29.71 $1.09 Million - $1.39 Million	46,791 Added 26.56%	222,983 $5.41 Million
Q4 2017 Feb 01, 2018	BUY	$25.82 - $35.66 $35,321 - $48,782	1,368 Added 0.78%	176,192 $4.91 Million
Q3 2017 Nov 02, 2017	BUY	$23.88 - $34.96 $4.17 Million - $6.11 Million	174,824	174,824 $5.99 Million

122

47.3M

200

12.8K

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $640M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

Get notified when there are updates to the investment portfolio of Bnp Paribas Asset Management Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Bnp Paribas Asset Management Holding S.A. with notifications on news.